Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17797-10-3

Post Buying Request

17797-10-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17797-10-3 Usage

Description

1-(4-FLUOROPHENYL)-1-METHYL-ETHYLAMINE is an organic compound that serves as a valuable synthetic intermediate in the pharmaceutical industry. It is characterized by its unique molecular structure, which includes a fluorophenyl group and a methylethylamine moiety. 1-(4-FLUOROPHENYL)-1-METHYL-ETHYLAMINE is known for its potential applications in the development of various pharmaceutical agents.

Uses

1. Used in Pharmaceutical Synthesis:
1-(4-FLUOROPHENYL)-1-METHYL-ETHYLAMINE is used as a synthetic intermediate for the development of potent cannabinoid CB1 receptor agonists. These agonists have potential therapeutic applications in treating various conditions, such as pain, inflammation, and anxiety, by modulating the endocannabinoid system.
2. Used in Pharmaceutical Synthesis (continued):
1-(4-FLUOROPHENYL)-1-METHYL-ETHYLAMINE is also utilized in the synthesis of potent antagonists of NPBWR1 (GPR7). These antagonists may have potential applications in the treatment of various disorders, including cardiovascular diseases, metabolic syndrome, and obesity, by targeting the NPBWR1 receptor.
3. Used in the Chemical Industry:
In addition to its pharmaceutical applications, 1-(4-FLUOROPHENYL)-1-METHYL-ETHYLAMINE may also be used as a building block or intermediate in the chemical industry for the synthesis of other complex organic molecules with diverse applications.

Check Digit Verification of cas no

The CAS Registry Mumber 17797-10-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,7,9 and 7 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 17797-10:
(7*1)+(6*7)+(5*7)+(4*9)+(3*7)+(2*1)+(1*0)=143
143 % 10 = 3
So 17797-10-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H12FN/c1-9(2,11)7-3-5-8(10)6-4-7/h3-6H,11H2,1-2H3

17797-10-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(4-Fluorophenyl)propan-2-amine

1.2 Other means of identification

Product number -
Other names 2-(4-fluorophenyl)propan-2-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17797-10-3 SDS

17797-10-3Relevant articles and documents

Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent

Gallardo-Macias, Ricardo,Kumar, Pradeep,Jaskowski, Mark,Richmann, Todd,Shrestha, Riju,Russo, Riccardo,Singleton, Eric,Zimmerman, Matthew D.,Ho, Hsin Pin,Dartois, Véronique,Connell, Nancy,Alland, David,Freundlich, Joel S.

supporting information, p. 601 - 606 (2019/01/04)

The optimization campaign for a nitrofuran antitubercular hit (N-benzyl-5-nitrofuran-2-carboxamide; JSF-3449) led to the design, synthesis, and biological profiling of a family of analogs. These compounds exhibited potent in vitro antitubercular activity (MIC = 0.019–0.20 μM) against the Mycobacterium tuberculosis H37Rv strain and low in vitro cytotoxicity (CC50 = 40–>120 μM) towards Vero cells. Significant improvements in mouse liver microsomal stability and mouse pharmacokinetic profile were realized by introduction of an α α-dimethylbenzyl moiety. Among these compounds, JSF-4088 is highlighted due to its in vitro antitubercular potency (MIC = 0.019 μM) and Vero cell cytotoxicity (CC50 > 120 μM). The findings suggest a rationale for the continued evolution of this promising series of antitubercular small molecules.

Evidence for significant through-space and through-bond electronic coupling in the 1,4-diphenylcyclohexane-1,4-diyl radical cation gained by absorption spectroscopy and DFT calculations

Ikeda, Hiroshi,Hoshi, Yosuke,Namai, Hayato,Tanaka, Futoshi,Goodman, Joshua L.,Mizuno, Kazuhiko

, p. 9207 - 9215 (2008/12/21)

Photoinduced single-electron-transfer promoted oxidation of 2,5-diphenyl-l,5-hexadiene by using N-methylquinolinium tetrafluoroborate/ biphenyl co-sensitization takes place with the formation of an intense electronic absorption band at 476 nm, which is attributed to the 1,4-diphenylcyclohexane-1,4-diyl radical cation. The absorption maximum (λob) of this transient occurs at a longer wavelength than is expected for either the cumyl radical or the cumyl cation components. Substitution at the para positions of the phenyl groups in this radical cation by CH3O, CH3, F, Cl, and Br leads to an increasingly larger redshift of λob. A comparison of the ρ value, which was obtained from a Hammett plot of the electronic transition energies of the radical cations versus σ+, with that for the cumyl cation shows that the substituent effects on the transition energies for the 1,4-diarylcyclohexane-1,4-diyl radical cations are approximately one half of the substituent effects on the transition energies of the cumyl cation. The observed substitu_ent-induced redshifts of λob and the reduced sensitivity of λob to substituent changes are in accordance with the proposal that significant through-space and -bond electronic interactions exist between the cumyl radical and the cumyl cation moieties of the 1,4-diphenylcyclohexane-1,4-diyl radical cation. This proposal gains strong support from the results of density functional theory (DFT) calculations. Moreover, the results of time-dependent DFT calculations indicate that the absorption band at 476 nm for the 1,4-diphenylcyclohexane-1,4-diyl radical cation corresponds to a SOMO-3-SOMO transition.

Heterosubstituted pyridine derivatives as PDE4 inhibitors

-

, (2008/06/13)

The invention encompasses the novel compound of Formula I useful in the treatment of diseases, including asthma, by raising the level of cyclic adenosine-3′,5′-monophosphate (cAMP) through the inhibition of phosphodiesterase IV (PDE 4). or a pharmaceutically acceptable salt or hydrate thereof. The invention also encompasses pharmaceutical compositions and methods for treatment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17797-10-3